453 related articles for article (PubMed ID: 14767470)
41. c-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes.
DeRita RM; Zerlanko B; Singh A; Lu H; Iozzo RV; Benovic JL; Languino LR
J Cell Biochem; 2017 Jan; 118(1):66-73. PubMed ID: 27232975
[TBL] [Abstract][Full Text] [Related]
42. Effect of type I growth factor receptor tyrosine kinase inhibitors on phosphorylation and transactivation activity of the androgen receptor in prostate cancer cells: Ligand-independent activation of the N-terminal domain of the androgen receptor.
Sugita S; Kawashima H; Tanaka T; Kurisu T; Sugimura K; Nakatani T
Oncol Rep; 2004 Jun; 11(6):1273-9. PubMed ID: 15138566
[TBL] [Abstract][Full Text] [Related]
43. Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling.
Sumitomo M; Shen R; Walburg M; Dai J; Geng Y; Navarro D; Boileau G; Papandreou CN; Giancotti FG; Knudsen B; Nanus DM
J Clin Invest; 2000 Dec; 106(11):1399-407. PubMed ID: 11104793
[TBL] [Abstract][Full Text] [Related]
44. Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.
Liu Y; Karaca M; Zhang Z; Gioeli D; Earp HS; Whang YE
Oncogene; 2010 Jun; 29(22):3208-16. PubMed ID: 20383201
[TBL] [Abstract][Full Text] [Related]
45. Focal adhesion kinase is required for bombesin-induced prostate cancer cell motility.
Lacoste J; Aprikian AG; Chevalier S
Mol Cell Endocrinol; 2005 May; 235(1-2):51-61. PubMed ID: 15866427
[TBL] [Abstract][Full Text] [Related]
46. Vascular endothelial growth factor C enhances cervical cancer migration and invasion via activation of focal adhesion kinase.
Chen H; Suo K; Cheng Y; Zheng B; Xu L
Gynecol Endocrinol; 2013 Jan; 29(1):20-4. PubMed ID: 22817694
[TBL] [Abstract][Full Text] [Related]
47. A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.
Hessenkemper W; Roediger J; Bartsch S; Houtsmuller AB; van Royen ME; Petersen I; Grimm MO; Baniahmad A
Mol Endocrinol; 2014 Nov; 28(11):1831-40. PubMed ID: 25203674
[TBL] [Abstract][Full Text] [Related]
48. Human cytomegalovirus chemokine receptor US28-induced smooth muscle cell migration is mediated by focal adhesion kinase and Src.
Streblow DN; Vomaske J; Smith P; Melnychuk R; Hall L; Pancheva D; Smit M; Casarosa P; Schlaepfer DD; Nelson JA
J Biol Chem; 2003 Dec; 278(50):50456-65. PubMed ID: 14506272
[TBL] [Abstract][Full Text] [Related]
49. Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase.
Zarif JC; Lamb LE; Schulz VV; Nollet EA; Miranti CK
Oncotarget; 2015 Mar; 6(9):6862-76. PubMed ID: 25730905
[TBL] [Abstract][Full Text] [Related]
50. A rapid, nongenomic, signaling pathway regulates the actin reorganization induced by activation of membrane testosterone receptors.
Papakonstanti EA; Kampa M; Castanas E; Stournaras C
Mol Endocrinol; 2003 May; 17(5):870-81. PubMed ID: 12554777
[TBL] [Abstract][Full Text] [Related]
51. Linking γ-aminobutyric acid A receptor to epidermal growth factor receptor pathways activation in human prostate cancer.
Wu W; Yang Q; Fung KM; Humphreys MR; Brame LS; Cao A; Fang YT; Shih PT; Kropp BP; Lin HK
Mol Cell Endocrinol; 2014 Mar; 383(1-2):69-79. PubMed ID: 24296312
[TBL] [Abstract][Full Text] [Related]
52. Crosstalk between EGFR and extranuclear steroid receptors.
Migliaccio A; Castoria G; Di Domenico M; Ciociola A; Lombardi M; De Falco A; Nanayakkara M; Bottero D; De Stasio R; Varricchio L; Auricchio F
Ann N Y Acad Sci; 2006 Nov; 1089():194-200. PubMed ID: 17261767
[TBL] [Abstract][Full Text] [Related]
53. Bradykinin enhances cell migration in human prostate cancer cells through B2 receptor/PKCδ/c-Src dependent signaling pathway.
Yu HS; Lin TH; Tang CH
Prostate; 2013 Jan; 73(1):89-100. PubMed ID: 22653778
[TBL] [Abstract][Full Text] [Related]
54. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
Mahajan NP; Liu Y; Majumder S; Warren MR; Parker CE; Mohler JL; Earp HS; Whang YE
Proc Natl Acad Sci U S A; 2007 May; 104(20):8438-43. PubMed ID: 17494760
[TBL] [Abstract][Full Text] [Related]
55. The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer.
Rocha J; Zouanat FZ; Zoubeidi A; Hamel L; Benidir T; Scarlata E; Brimo F; Aprikian A; Chevalier S
Mol Cell Endocrinol; 2013 Dec; 381(1-2):140-9. PubMed ID: 23906537
[TBL] [Abstract][Full Text] [Related]
56. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways.
Ueda T; Bruchovsky N; Sadar MD
J Biol Chem; 2002 Mar; 277(9):7076-85. PubMed ID: 11751884
[TBL] [Abstract][Full Text] [Related]
57. c-Src and cooperating partners in human cancer.
Ishizawar R; Parsons SJ
Cancer Cell; 2004 Sep; 6(3):209-14. PubMed ID: 15380511
[TBL] [Abstract][Full Text] [Related]
58. Ror2-Src signaling in metastasis of mouse melanoma cells is inhibited by NRAGE.
Lai SS; Xue B; Yang Y; Zhao L; Chu CS; Hao JY; Wen CJ
Cancer Genet; 2012 Nov; 205(11):552-62. PubMed ID: 23142633
[TBL] [Abstract][Full Text] [Related]
59. Requirement of androgen-dependent activation of protein kinase Czeta for androgen-dependent cell proliferation in LNCaP Cells and its roles in transition to androgen-independent cells.
Inoue T; Yoshida T; Shimizu Y; Kobayashi T; Yamasaki T; Toda Y; Segawa T; Kamoto T; Nakamura E; Ogawa O
Mol Endocrinol; 2006 Dec; 20(12):3053-69. PubMed ID: 16931574
[TBL] [Abstract][Full Text] [Related]
60. Expression of focal adhesion kinase in normal and pathologic human prostate tissues.
Rovin JD; Frierson HF; Ledinh W; Parsons JT; Adams RB
Prostate; 2002 Oct; 53(2):124-32. PubMed ID: 12242727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
